Search

Your search keyword '"Follmann, Markus"' showing total 633 results

Search Constraints

Start Over You searched for: Author "Follmann, Markus" Remove constraint Author: "Follmann, Markus"
633 results on '"Follmann, Markus"'

Search Results

1. Implications of the COVID-19 Pandemic for the Development and Update of Clinical Practice Guidelines: Viewpoint

9. GGPONC: A Corpus of German Medical Text with Rich Metadata Based on Clinical Practice Guidelines

13. The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development

14. German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023

20. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion.

21. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Kurzversion.

23. Soluble Guanylate Cyclase Stimulators and Activators

25. Methodischer Standard für die Entwicklung von Qualitätsindikatoren im Rahmen von S3-Leitlinien – Ergebnisse einer strukturierten Konsensfindung

26. S2k guideline basal cell carcinoma of the skin (update 2023).

27. S2k‐Leitlinie Basalzellkarzinom der Haut (Aktualisierung 2023).

28. Soluble GC stimulators and activators: Past, present and future.

30. S2k guideline basal cell carcinoma of the skin (update 2023)

32. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion

33. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0

34. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion

35. Leitlinienreport der S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms und biliärer Karzinome“

36. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0

37. Bringing two worlds closer together: a critical analysis of an integrated approach to guideline development and quality assurance schemes

43. Recommendations to improve use and dissemination of patient versions of oncological clinical practice guidelines in Germany: results of a multi-stakeholder workshop

44. S3‐Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 2: Epidemiologie und Ätiologie, Diagnostik, Therapie des invasiven Plattenepithelkarzinoms der Haut, Nachsorge und Prävention

45. Evaluation of patient versions of oncological guidelines

46. S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention

47. Barriers and facilitators in developing patient versions of clinical practice guidelines - qualitative interviews on experiences of international guideline producers

48. S3‐Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen

49. S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“– update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care

50. Correction to: Soluble Guanylate Cyclase Stimulators and Activators

Catalog

Books, media, physical & digital resources